+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Analysis of the differences in structural chromosomal aberrations of the gastric mucosa between H-pylori positive and negative gastric cancer patients: Involvement of H-pylori in the onset of gastric cancer and examination of the mechanism in gastric carcinogenesis following H-pylori eradication



Analysis of the differences in structural chromosomal aberrations of the gastric mucosa between H-pylori positive and negative gastric cancer patients: Involvement of H-pylori in the onset of gastric cancer and examination of the mechanism in gastric carcinogenesis following H-pylori eradication



Oncology Reports 16(6): 1333-1342



mutations are essential to carcinogenesis. If an evident difference is observed in gastric mucosal chromosomal structure aberrations between H. pylori (Hp)-negative and Hp-positive gastric cancer patients, it may be interpreted as suggesting the involvement of Hp in gene mutations. This study was undertaken to compare chromosomal structural aberrations between Hp-negative and Hp-positive gastric cancer patients and to evaluate the effects of Hp eradication on chromosomal structures in clinical cases. The subjects of this study were 40 patients with gastric cancer divided into four groups: Group A was composed of 12 patients with Hp-negative gastric cancer (well-differentiated gastric cancer in 5 cases and poorly-differentiated in 7 cases), Group B of 8 patients with Hp-negative gastric cancer following Hp eradication (well-differentiated in 4 case and poorly-differentiated in 4 cases), Group C of 13 patients with Hp-positive gastric cancer (well-differentiated in 7 cases and poorly-differentiated in 6 cases) and Group D of 7 patients with gastric cancer (well-differentiated in 5 cases and poorly-differentiated in 2 cases) undergoing Hp eradication at subtotal gastrectomy. In each of the groups A, B and C, the structural chromosomal aberration such as loss of heterozygosity (LOH) and microsatellite instability (MSI) was analyzed. In Group D, changes in structural chromosomal aberrations after Hp eradication as compared to the pre-eradication structures were also analyzed. LOH and MSI were examined by PCR, using DNA extracted from the cancer-affected and intact gastric mucosal tissue specimens from each patient. In A, B and C-groups, structural chromosomal aberrations were noted, and these aberrations tended to be more marked in cases of poorly-differentiated gastric cancer in each group. In terms of structural chromosomal aberrations, there was no marked difference between Group A and either Group B or C. Hp eradication resulted in no change in chromosomal structure as compared to the pre-eradication structure in Group D. These results suggest the possibility that Hp eradication does not affect chromosomal structures and Hp is involved in gastric carcinogenesis as an additive environmental factor rather than as a factor acting at the gene level.

(PDF emailed within 1 workday: $29.90)

Accession: 012838411

Download citation: RISBibTeXText

PMID: 17089058


Related references

Role of metallothionein in Helicobacter pylori-positive gastric mucosa with or without early gastric cancer and the effect on its expression after eradication therapy. Journal of Gastroenterology and Hepatology 23(8 Pt 2): E334-E339, 2007

Effects of Helicobacter pylori eradication on the background gastric mucosa in the patients after endoscopic mucosal resection of early gastric cancer. Gastroenterology 118(4 Suppl 2 Part 1): AGA A502, 2000

Effect of eradication of Helicobacter pylori on expression levels of FHIT, IL-8 and P73 in gastric mucosa of first-degree relatives of gastric cancer patients. Plos One 10(4): E0124576, 2016

Mo1149 Molecular Background of Development of Gastric Mucosa Changes in H. Pylori Infected Patients With Chronic Gastritis Gastric Cancer and Familial Cases of Gastric Cancer. Gastroenterology 144(5): S-592, 2013

Effect of Helicobacter pylori eradication on the expression level of SATB1 and c-Myc genes in gastric mucosa of patients with family history of gastric cancer. Polski Merkuriusz Lekarski 34(203): 269-276, 2013

Helicobacter pylori infection associates with cyclo-oxygenase-2 expression in human gastric mucosa-A possible role of COX-2 in H pylori-related gastric carcinogenesis. Gastroenterology 116(4 PART 2): A303, 1999

Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer. Scandinavian Journal of Gastroenterology 48(11): 1249-1256, 2014

Telomere length in the gastric mucosa after Helicobacter pylori eradication and its potential role in the gastric carcinogenesis. Clinical and Experimental Medicine 18(1): 21-26, 2017

Changes of pepsinogens I and II in the gastric mucosa of patients with H pylori-positive gastroduodenal disease who were followed over a year after eradication of H pylori An immunohistochemical study. Gastroenterology 116(4 PART 2): A156, 1999

Magnifying NBI Patterns of Gastric Mucosa After Helicobacter pylori Eradication and Its Potential Link to the Gastric Cancer Risk. Digestive Diseases and Sciences 62(9): 2421-2427, 2017

S1606 Ten-Year Follow-Up Study On the Incidence of Gastric Cancer and the Pathological Changes of Gastric Mucosa After H. pylori Eradication in China. Gastroenterology 134(4): A-233, 2008

Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer. Gastric Cancer 19(1): 160-165, 2017

Eradication of Helicobacter pylori, improvement of gastritis, and the normalization of the hyperproliferative state of gastric mucosa did not prevent a case of gastric cancer. Journal of Clinical Gastroenterology 28(2): 178-179, 1999

Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Gut and Liver 10(5): 706-713, 2017

Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence. Apmis 114(5): 372-380, 2006